Biopharmaceutical Excipients Market

Report Highlights

The report broadly covers different types of biopharmaceutical excipients based on their product. Furthermore, the scope of the report also covers the impact of COVID-19 and drivers and challenges for Biopharmaceutical Excipients market. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each product, formulation, functionality, and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional biopharmaceutical excipients markets; it explains the major market drivers of the global biopharmaceutical excipients industry, current trends within the industry, major applications, and the regional dynamics of the global biopharmaceutical excipients market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the global biopharmaceutical excipients market.

Report Includes

• 35 tables and 43 figures
• An up-to-date analysis of the Global Biopharmaceutical Excipients Market.
• Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
• Estimation of market size and revenue forecast for Global Biopharmaceutical Excipients Market, and corresponding market share analysis by product, formulation, functionality, and region.
• Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Biopharmaceutical Excipients, identification of the companies that are best positioned to meet this demand.
• In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
• Identification of promising new products still in the development and testing stages, and their probability of successful commercial launch within the next five years
• Impact of COVID-19 on the Biopharmaceutical Excipients Market as compared to overall global economy.
• Insight into the growth development strategies of major Biopharmaceutical Excipients manufacturers and their key competitive landscape
• Descriptive company profiles of the leading market participants, including Merck KGaA, Colorcon, Inc., Associated British Foods plc, IMCD N.V., Sigachi Industries Limited, DMV-Fonterra Excipients GmbH & Co. KG, and others.

Summary

Excipients play an important role in biopharmaceuticals by facilitating the effective binding of components, revising the solubility and bioavailability of API, and enhancing drug stability in the prescription form. Hence, choosing the accurate excipient is essential for lowering the production costs and helps in enhancing the patient’s experience. The variety of the right excipient helps in surmounting several disputes associated with biopharmaceuticals. For instance, there are numerous drugs such as protein-based drugs that are usually associated with the uncertainty that requires the method of lyophilization.

However, lyophilization is a very much time and energy-consuming process. Hence, the amalgamation of drug-specific excipients provides significantly to preserving the constancy of a biologically active ingredient which implicitly affects the time needed for lyophilization. Excipients are durable and reproducible, pharmacologically static, and cost-effective. They are comprised of wheat, corn, minerals, sugar, and other such ingredients. Biopharmaceutical excipients are accessible in different types of creations such as topical creams, capsules, injectables, tablets, gels, and transdermal patches.